DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal Atrophy-Phase I Randomized,Placebo-Controlled, Double-Blind Study.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Prasterone (Primary)
- Indications Atrophic vaginitis
- Focus Pharmacokinetics
- 07 Apr 2017 Biomarkers information updated
- 10 Jan 2013 According to the ClinicalTrials.gov record, the recruitment status of this study is unknown because the information has not been verified recently (last verified Jan 2007).
- 10 Jan 2013 New trial record